FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years

NCT00161850 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
615
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer